ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,588Medicare Part D Prescriptions Filled, Including Refills

Rank: 287 out of 1904

$907K Total Retail Price of All Prescriptions

Rank: 114 out of 1904

430 Patients Receiving at Least One Drug in Part D
76% Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Indiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 430 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 430 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$86 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 700 530 118 1 1
ATORVASTATIN CALCIUM 595 325 93 2 8
LOSARTAN POTASSIUM 355 211 67 3 21
OMEPRAZOLE 282 141 44 4 5
SIMVASTATIN 230 175 55 5 4
HYDROCODONE-ACETAMINOPHEN 225 158 38 S3 6 2
MELOXICAM 218 169 43 7 29
AMLODIPINE BESYLATE 194 133 34 8 6
TAMSULOSIN HCL 170 108 29 9 26
ZOLPIDEM TARTRATE 169 122 34 10 30
NEXIUM 147 27 20 11 37
FUROSEMIDE 146 84 28 12 7
MONTELUKAST SODIUM 128 100 28 13 53
DIOVAN 122 89 24 14 61
POLYETHYLENE GLYCOL 3350 119 15 18 15 50
CYMBALTA 113 59 25 16 34
TIZANIDINE HCL 111 49 23 17 131
GABAPENTIN 105 74 22 18 13
METOPROLOL SUCCINATE 103 65 19 19 16
FLUTICASONE PROPIONATE 102 65 26 20 49
CLOPIDOGREL 101 81 20 21 20
METFORMIN HCL ER 94 68 16 22 51
PANTOPRAZOLE SODIUM 93 88* 20 23 27
CHLORHEXIDINE GLUCONATE 93 <11 <11 23 240
LISINOPRIL 85 54 22 25 3
FENOFIBRATE* 84 66 13 26 70
TRAMADOL HCL 83 49 21 27 18
LOSARTAN-HYDROCHLOROTHIAZIDE 79 43 15 28 48
BISOPROLOL FUMARATE 75 70* 15 29 263
CRESTOR 75 57 19 29 33
CLONAZEPAM 75 44 15 B 29 44
CELEBREX 75 22 13 29 85
SYNTHROID 74 74 25 33 42
NAMENDA 73 <11 <11 34 28
CARVEDILOL 71 <11 <11 35 24
ADVAIR DISKUS 71 <11 <11 35 56
FAMOTIDINE* 69 <11 <11 37 67
RENACIDIN 69 <11 <11 10 37 416
LORAZEPAM 68 55 25 B 39 36
SERTRALINE HCL 65 42 11 40 25
AMITIZA 65 <11 <11 40 224
BACLOFEN 64 <11 <11 42 116
BD ULTRA-FINE PEN NEEDLE 62 37 17 43 106
BYSTOLIC 60 55* 11 44 90
ROPINIROLE HCL 58 <11 <11 45 75
JANUVIA 58 45 13 45 69
ALENDRONATE SODIUM 57 <11 <11 47 35
ALPRAZOLAM 56 37 13 B 48 15
ATENOLOL 56 33 13 48 19
ALLOPURINOL 55 55 14 50 31
FENOFIBRATE* 54 <11 <11 51 70
POTASSIUM CHLORIDE 52 19 11 52 17
VALSARTAN-HYDROCHLOROTHIAZIDE 52 52 13 52 89
TRADJENTA 51 <11 <11 54 297
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.